Aligos Therapeutics, Inc. (ALGS) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 59.63M | 82.86M | 103.44M | 127.94M | 143.21M | 62.14M | 79.82M | 99.57M | 118.06M | 141.08M | 74.64M | 94.24M |
| Cash & Short-Term Investments | 55.08M | 77.95M | 99.1M | 122.94M | 137.86M | 56.94M | 74.92M | 94.54M | 112.74M | 135.7M | 70.43M | 90.84M |
| Cash Only | 30.15M | 18.41M | 41.95M | 18.66M | 73.76M | 37M | 35.33M | 45.08M | 24.15M | 135.7M | 70.43M | 90.83M |
| Short-Term Investments | 24.93M | 59.54M | 57.15M | 104.28M | 64.1M | 19.94M | 39.59M | 49.46M | 88.59M | 0 | 0 | 10K |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.55M | 4.91M | 4.34M | 5M | 5.34M | 5.2M | 4.9M | 5.03M | 5.33M | 5.38M | 4.21M | 3.4M |
| Total Non-Current Assets | 4.93M | 6.72M | 6.33M | 6.76M | 7.49M | 7.95M | 8.6M | 9.24M | 9.84M | 10.44M | 11.21M | 11.89M |
| Property, Plant & Equipment | 4.17M | 4.96M | 5.62M | 6.12M | 6.86M | 7.33M | 7.97M | 8.61M | 9.21M | 9.82M | 10.59M | 11.26M |
| Fixed Asset Turnover | 0.62x | 0.03x | 0.13x | 0.15x | 0.04x | 0.08x | 0.15x | 0.12x | 0.10x | 0.26x | 0.30x | 0.60x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 759K | 715K | 713K | 640K | 632K | 627K | 635K | 631K | 625K | 625K | 623K | 624K |
| Total Assets | 64.56M | 89.58M | 109.76M | 134.71M | 150.7M | 70.09M | 88.43M | 108.81M | 127.9M | 151.53M | 85.85M | 106.13M |
| Asset Turnover | 0.04x | 0.00x | 0.01x | 0.01x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.03x | 0.06x |
| Asset Growth % | -57.16% | 27.8% | 24.13% | 23.8% | 17.82% | -53.74% | 3% | 2.53% | 5.06% | 3.3% | -47.67% | -41.85% |
| Total Current Liabilities | 23.32M | 21.23M | 21.99M | 20.27M | 18.95M | 21.74M | 20.96M | 23.56M | 18.88M | 23.91M | 22.47M | 27.23M |
| Accounts Payable | 7.64M | 3.98M | 4.65M | 3.94M | 4.46M | 2.57M | 2.74M | 6.82M | 2.84M | 2.52M | 2.94M | 3.24M |
| Days Payables Outstanding | - | 1.55K | - | 1.48K | - | - | - | 720.62 | - | - | - | - |
| Short-Term Debt | 3.69M | 3.73M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 168K | 579K | 0 | 151K | 655K | 1.33M | 721K | 1.31M | 3.95M | 6.95M |
| Other Current Liabilities | 7.77M | 6.06M | 13.61M | 4.42M | 3.45M | 6.39M | 4.41M | 3.6M | 3.06M | 6.67M | 4.09M | 3.16M |
| Current Ratio | 2.56x | 3.90x | 4.70x | 6.31x | 7.56x | 2.86x | 3.81x | 4.23x | 6.25x | 5.90x | 3.32x | 3.46x |
| Quick Ratio | 2.56x | 3.90x | 4.70x | 6.31x | 7.56x | 2.86x | 3.81x | 4.23x | 6.25x | 5.90x | 3.32x | 3.46x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 9.45M | 14.8M | 15.94M | 12.57M | 15.31M | 77.33M | 17.37M | 18.02M | 49.23M | 35.54M | 8.56M | 9.27M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 659K | 1.52M | 2.5M | 3.34M | 4.39M | 4.92M | 5.73M | 6.48M | 7.21M | 7.9M | 8.52M | 9.18M |
| Deferred Tax Liabilities | 0 | 1.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 8.79M | 12.23M | 13.44M | 9.24M | 10.92M | 72.41M | 11.64M | 11.54M | 42.02M | 27.64M | 46K | 0 |
| Total Liabilities | 32.77M | 36.04M | 37.93M | 32.84M | 34.25M | 99.07M | 38.33M | 41.58M | 68.11M | 59.45M | 31.03M | 36.49M |
| Total Debt | 4.35M | 5.25M | 6.07M | 6.88M | 7.87M | 8.38M | 9.13M | 9.84M | 10.48M | 11.14M | 11.77M | 12.41M |
| Net Debt | -25.8M | -13.16M | -35.88M | -11.78M | -65.89M | -28.62M | -26.2M | -35.24M | -13.67M | -124.57M | -58.66M | -78.41M |
| Debt / Equity | 0.14x | 0.10x | 0.08x | 0.07x | 0.07x | - | 0.18x | 0.15x | 0.18x | 0.12x | 0.21x | 0.18x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 31.79M | 53.55M | 71.83M | 101.87M | 116.44M | -28.97M | 50.1M | 67.23M | 59.8M | 92.08M | 54.82M | 69.64M |
| Equity Growth % | -72.7% | 284.81% | 43.39% | 51.52% | 94.74% | -131.47% | -8.62% | -3.46% | -29.44% | -11.38% | -55.07% | -49.16% |
| Book Value per Share | 3.06 | 5.16 | 6.93 | 9.84 | 13.37 | -4.61 | 7.99 | 10.73 | 3.84 | 3.70 | 1.26 | 1.61 |
| Total Shareholders' Equity | 31.79M | 53.55M | 71.83M | 101.87M | 116.44M | -28.97M | 50.1M | 67.23M | 59.8M | 92.08M | 54.82M | 69.64M |
| Common Stock | 9K | 9K | 9K | 9K | 9K | 8K | 8K | 8K | 7K | 7K | 4K | 4K |
| Retained Earnings | -665.24M | -642.2M | -622.32M | -590.78M | -574.92M | -618.01M | -535.86M | -516.6M | -521.66M | -486.8M | -458.9M | -440.86M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 438K | 468K | 455K | 420K | 447K | 451K | 577K | 494K | 476K | 545K | 497K | 497K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |